Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
1 drugs in development
By Therapeutic Area
top 3
R&D Momentum
58/100
Pipeline Velocity
19/100
Trial Completion Rate
100/100
Pipeline Concentration
33/100
Pipeline Freshness
12/100
Strategic Signals
Activity
Last 14 days
Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Omega-3 Fatty Acid Supplementation for Adult and Juvenile Dermatomyositis (DM/JDM)
COVID-19 Experiences in the SELF Cohort: A Cross-Sectional Study
Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases
Agricultural Health Study: Health Followup
Reproductive Axis Maturation in the Early Post-Menarchal Years: A Pilot Study
Factors Influencing Fertility or Pregnancy Health
Gulf STUDY: Gulf Long-Term Follow-Up Study
The Role of Gonadotropin Pulsations in the Regulation of Puberty and Fertility
Cytochrome P450 Epoxygenase Pathway Regulation of Macrophage Function
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)